Eberhard H. Uhlenhuth
#140,247
Most Influential Person Now
Eberhard H. Uhlenhuth's AcademicInfluence.com Rankings
Download Badge
Psychology
Eberhard H. Uhlenhuth's Degrees
- PhD Psychology University of Maryland, College Park
- Masters Psychology University of Maryland, College Park
- Bachelors Psychology University of Maryland, College Park
Similar Degrees You Can Earn
Why Is Eberhard H. Uhlenhuth Influential?
(Suggest an Edit or Addition)Eberhard H. Uhlenhuth's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. (1974) (4317)
- Insomnia and its treatment. Prevalence and correlates. (1985) (1027)
- The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. (1974) (911)
- Scaling of life events. (1971) (750)
- Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. (1994) (340)
- Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use. (1983) (240)
- Prevalence and correlates of the long‐term regular use of anxiolytics (1984) (225)
- Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. (1986) (216)
- New epidemiologic findings about insomnia and its treatment. (1992) (171)
- A cross-national comparison of anti-anxiety/sedative drug use. (1984) (157)
- Moclobemide in social phobia: a controlled dose-response trial. (1997) (153)
- LENGTH OF TREATMENT WITH ANXIOLYTIC SEDATIVES AND RESPONSE TO THEIR SUDDEN WITHDRAWAL (1973) (149)
- Psychiatric screening in a medical clinic. An evaluation of a self-report inventory. (1978) (133)
- Individual differences in behavioral and subjective responses to alcohol. (1987) (126)
- Symptom intensity and life events. (1973) (116)
- Symptom intensity and life stress in the city. (1974) (115)
- Reinforcing and subjective effects of several anorectics in normal human volunteers. (1987) (106)
- Personality dimensions in panic disorder and generalized anxiety disorder. (1996) (106)
- The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans (1986) (104)
- Drug preference and mood in humans: Diazepam (2004) (103)
- Drug preference and mood in humans: d-amphetamine (2004) (96)
- The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo. (1959) (96)
- Factors of symptom distress. Doctor ratings of anxious neurotic outpatients. (1969) (87)
- International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. (1999) (81)
- Minor tranquilizers: clinical correlates of use in an urban population. (1978) (80)
- Drug preference and mood in humans: Repeated assessment of d-amphetamine (1981) (79)
- Risks and Benefits of Long‐Term Benzodiazepine Use (1988) (79)
- Cognitive Dysfunction and Imipramine in Outpatient Depressives (1981) (74)
- Lack of preference for diazepam in anxious volunteers. (1986) (73)
- Remembering Life Events (1977) (73)
- Symptom configuration and life events. (1973) (70)
- Escitalopram: an open-label study of bereavement-related depression and grief. (2009) (66)
- Replication Of Symptom Distress Factors In Anxious Neurotic Outpatients. (1968) (63)
- Cocaine : clinical and biobehavioral aspects (1987) (63)
- Drug preferences in humans. (1982) (59)
- Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy (2004) (58)
- Response of panic disorder to fixed doses of alprazolam or imipramine. (1989) (53)
- Neurotics Who Fail to Take their Drugs (1965) (53)
- Combined pharmacotherapy and psychotherapy. (1969) (52)
- The beneficial and adverse effects of hypnotics. (1991) (49)
- The phenomenology of panic attacks in panic disorder with and without agoraphobia. (1993) (48)
- Long‐term effectiveness of cognitive therapy in major depressive disorder (2004) (48)
- Dimensions of symptom distress in anxious neurotic outpatients. (1969) (47)
- Subjective change with medical student therapists. II. Some determinants of change in psychoneurotic outpatients. (1968) (45)
- THE INFLUENCE OF MEDICATION (IMIPRAMINE) AND DOCTOR IN RELIEVING DEPRESSED PSYCHONEUROTIC OUTPATIENTS. (1964) (45)
- Changes in popular attitudes and beliefs about tranquilizers. 1970-1979. (1986) (44)
- International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. (1995) (43)
- The discriminative stimulus and subjective effects of d-amphetamine in humans (2004) (42)
- Patterns of comorbidity in panic disorder and agoraphobia (1992) (40)
- Panic disorder and hypochondriacal fears and beliefs. (1992) (39)
- Review of the long‐term effectiveness of cognitive behavioral therapy compared to medications in panic disorder (2003) (38)
- Reinforcing properties of lorazepam in normal volunteers. (1984) (37)
- Panic disorder, agoraphobia, and anxiety-relevant cognitive style. (1986) (36)
- Anti-anxiety agents: duration of use and characteristics of users in the U.S.A. (1984) (36)
- Medication side effects in anxious patients: negative placebo responses? (1998) (35)
- Evaluating a household survey measure of psychic distress (1983) (33)
- Lack of preference for flurazepam in normal volunteers (1984) (32)
- Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity (1993) (31)
- Rating the Magnitude of Life Stress * (1972) (29)
- The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans (2004) (29)
- Growing placebo response rate: the problem in recent therapeutic trials? (1997) (28)
- Hopkins Symptom Checklist (2013) (27)
- International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: III. Clinical features affecting experts' therapeutic recommendations in anxiety disorders. (1995) (27)
- AN EXTENSION OF THE WHITEHORN‐BETZ A‐B SCALE (1968) (27)
- Drug preference and mood in humans: Preference for d-amphetamine and subject characteristics (2004) (27)
- Assessment of dependence potential of drugs in humans using multiple indices (2004) (26)
- Generalized anxiety disorder, worries about illness, and hypochondriacal fears and beliefs. (1994) (26)
- Individual differences in the discriminative stimulus effects of d‐amphetamine in humans (1989) (25)
- Interactive Model of Therapeutic Response in Panic Disorder: Moclobemide, a Case in Point (2002) (24)
- Preference for Diazepam in Anxious Adults (1990) (24)
- Plasma dopamine-beta-hydroxylase in depressed patients. (1982) (23)
- An experimental paradigm for studying the discriminative stimulus properties of drugs in humans (2004) (22)
- A single dose study of nabilone, a synthetic cannabinoid (2004) (22)
- A Comparison of Doctor and Patient Improvement Ratings in a Drug (Meprobamate) Trial (1965) (22)
- Drug effects and initial severity of symptomatology (1965) (22)
- The reinforcing properties of amphetamine in overweight subjects and subjects with depression (1987) (21)
- The Rating and Self-rating of Anxiety (1991) (21)
- Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists’ treatment choices (2004) (20)
- The revised Anxious Thoughts and Tendencies (AT&T) scale: a general measure of anxiety-prone cognitive style. (1999) (20)
- A general anxiety-prone cognitive style in anxiety disorders. (2002) (20)
- DOSAGE DEVIATION AND DRUG EFFECTS IN DRUG TRIALS (1965) (20)
- Psychopathology of panic attacks in panic disorder. (2006) (19)
- Anxiety disorders: prevalence and treatment. (1984) (18)
- Mitral valve prolapse and thyroid abnormalities in patients with panic attacks. (1987) (18)
- International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997. (1998) (17)
- Smooth-pursuit eye movements, and diazepam, CPZ, and secobarbital (1975) (17)
- The Value of Self‐Report Assessment in Studies of Anxiety Disorders (1987) (17)
- EFFECTS OF INFORMED CONSENT ON RESEARCH PATIENTS AND STUDY RESULTS (1967) (15)
- Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication. (2000) (15)
- SOME FACTORS INFLUENCING THE TREATMENT EXPECTATIONS OF ANXIOUS NEUROTIC OUTPATIENTS (1967) (15)
- Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992–1997 (1998) (15)
- The Tridimensional Personality Questionnaire as an Instrument for Screening Personality Disorders: Use in Patients with Generalized Anxiety Disorder (1995) (14)
- Drug self-administration in humans. (1978) (14)
- Personality dimensions in panic disorder before and after effective treatment. (1996) (13)
- Comorbidity rates do not support distinction between panic disorder and generalized anxiety disorder. (1994) (13)
- Drug preference in normal volunteers: Effects of age and time of day (2004) (13)
- Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers (2004) (13)
- Subjective change with medical student therapists. I. Course of relief in psychoneurotic outpatients. (1968) (13)
- Prescribing and use of benzodiazepines: an epidemiologic perspective. (1992) (13)
- Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992–1997 (1998) (13)
- "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic". (1982) (12)
- The dependence potential of benzodiazepines. (1984) (10)
- Diphenylhydantoin effectiveness in the treatment of chronic schizophrenics. A double-blind controlled study with a placebo. (1974) (10)
- The effects of two nonpharmacological variables on drug preference in humans. (1983) (10)
- Comparison of primary and secondary panic disorder: a preliminary report. (1993) (9)
- Phenylpropanolamine: reinforcing and subjective effects in normal human volunteers (2004) (9)
- Plasma concentrations of imipramine and clinical response among depressed outpatients. (1982) (9)
- Is a double-blind clinical trial really double-blind? (2004) (8)
- Predicting the relief of anxiety with meprobamate. Nondrug factors in the response of psychoneurotic outpatients. (1968) (7)
- Clinical variables in pharmacoepidemiology. (1993) (7)
- Disability and Comorbidity: Diagnoses and Symptoms Associated with Disability in a Clinical Population with Panic Disorder (2014) (7)
- Predicting the relief of anxiety with meprobamate. An attempt at replication. (1972) (7)
- Cognitive dysfunction and imipramine in outpatient depressive. (1981) (7)
- Depressives, doctors, and antidepressants. (1982) (7)
- Correlates of mitral valve prolapse among patients with panic disorder (1989) (7)
- The effects of nabilone, a synthetic cannabinoid, on anxious human volunteers [proceedings]. (1979) (6)
- Human drug discrimination: d-amphetamine and other anorectics. (1986) (6)
- A Computer Study of Selected Features of Self-and-Other Drawings by 385 Children (1972) (6)
- Side reactions on meprobamate and placebo. (1967) (6)
- Improved statistical analysis of moclobemide dose effects on panic disorder treatment (2010) (6)
- Medication attitudes and drug response. (1969) (6)
- Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses. (1970) (6)
- Evaluating antianxiety agents in humans: experimental paradigms. (1977) (6)
- Diazepam preference in subjects seeking treatment for anxiety. (1987) (5)
- Medication, anxiety reduction and patient report of significant life situation events. (1971) (5)
- Drug preference and mood in humans: mazindol and phenylpropanolamine. (1984) (5)
- Intensive design in evaluating anxiolytic agents (1977) (5)
- COMBINED PHARMACOTHERAPY AND PSYCHOTHERAPY: CONTROLLED STUDIES (1969) (4)
- Multiple crossover designs with an antianxiety agent and an antidepressant. (1979) (3)
- Responses of chronic schizophrenic females to a combination of diphenylhydantoin and neuroleptics: a double-blind study. (1975) (3)
- SKED program for a modified sternberg procedure (1975) (3)
- Validation of the MacAndrew-Rosen drug therapy scale. (1970) (3)
- Reinforcement, skin conductance, and performance in a vigilance-reaction time task (1981) (3)
- Differential reliability in rating psychopathology and global improvement (1970) (3)
- Growing placebo response rate (1997) (2)
- Drug preference in humans: lorazepam. (1984) (2)
- Subject-own-control design in evaluating clinical antidepressant effects. (1982) (2)
- Diphenylhydantoin and phenobarbital in the relief of psychoneurotic symptoms (2004) (1)
- Issues in the long-term treatment of panic disorder. (1998) (1)
- The Response to Meprobamate: A Predictive Analysis (1971) (1)
- Introduction: Issues in The Long-Term Treatment of Panic Disorder (1998) (1)
- Subjective change with the initial interview. (1969) (1)
- Dispelling myths about benzodiazepines. (1999) (1)
- Issues in evaluating the effects of psychotropic drugs on human performance measures [proceedings]. (1979) (1)
- Prevalence and correlates of the long-term regular use of anxiolytics (1984) (1)
- Panic disorder and agoraphobia: a sufferer's perspective. (1998) (0)
- Efficacy of cognitive-behaviour therapy alone and cognitive-behaviour therapy combined with pharmacotherapy in the treatment of panic disorder with agoraphobia (1999) (0)
- II The morality of scientists (1987) (0)
- Growing placebo effect — The problem in recent therapeutic trials? (1996) (0)
- TREATMENT CHOICES AND STRATEGIES FOR SOME COMMON PSYCHIATRIC CONDITIONS (1994) (0)
- Hopkins Symptom Checklist, Depression Items (HSCL) 1974 (1981) (0)
- Mitchell B. Balter, PhD???Psychopharmacologist and: Pharmacoepidemiologist (1994) (0)
- On drugs and the person. (1966) (0)
- Symptom Distress Checklist-31 (2015) (0)
- SYMPOSIUM ON EXPERT OPINION ABOUT THE USE OF PSYCHOTHERAPEUTIC MEDICATIONS (1994) (0)
- Correction of Error in Diagnosis (1982) (0)
- Guidelines for investigation of allegations of dishonesty in research. (1987) (0)
- The Measurement of Anxiety (2019) (0)
- P.3.037 Treatment decision-making in panic disorder with agoraphobia (2003) (0)
- Treatment of Depression-Reply (1983) (0)
- Changes in recommendations for the treatment of panic disorder by an international panel of experts, 1992–1997 (1998) (0)
- INDICATIONS FOR PSYCHOPHARMACOLOGIC TREATMENT ACROSS A BROAD SPECTRUM OF PSYCHIATRIC DISORDERS (1994) (0)
- Contents, Vol. 27, 1994 (1994) (0)
- Past and forthcoming meetings (1987) (0)
- Ordinal sibling position and motivation toward psychiatric treatment. (1962) (0)
- INTERCHANGEABILIY OF MEDICATIONS IN THE TREATMENT OF SOME COMMON PSYCHIATRIC DISORDERS (1994) (0)
- Specific anxiety syndromes: current therapeutic options. (1981) (0)
- Revised Anxious Thoughts and Tendencies Scale (2012) (0)
- Research report Psychopathology of panic attacks in panic disorder (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eberhard H. Uhlenhuth?
Eberhard H. Uhlenhuth is affiliated with the following schools:
